The R&D budget is slashed, but there’s a silver lining to the economic crisis as the costs of innovation, entrepreneurship and building new companies are reduced.
Austerity measures are leading to changes in tuition fees, collaboration with industry, philanthropic funding and funding from donations, says European University Association.
Index Ventures raised $400 million dollars in its last fund, of which about half will be invested in life science start-ups. Senior partner, Francesco de Rubertis says personalised medicine will take a large share of this.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.